Beacon Therapeutics
Last updated: July 11, 2025
CEO - David Fellows
Country: UK | Funding: $290.1M (+) | Add Funding
Website: https://www.beacontx.com
Beacon Therapeutics is an ophthalmic gene therapy company to treat blinding retinal illnesses and restore and enhance eyesight.
Website: https://www.beacontx.com
Beacon Therapeutics is an ophthalmic gene therapy company to treat blinding retinal illnesses and restore and enhance eyesight.
